DCM
ORCL icon

Dilation Capital Management’s Oracle ORCL Stock Holding History

Dilation Capital Management’s Portfolio ORCL Stock Details ORCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,080
Closed -$4.52M – 23
2025
Q3 		$4.52M Buy
+16,080
New +$4.09M 2.24% 20
2025
Q1 		– Sell
-11,600
Closed -$1.93M – 20
2024
Q4 		$1.93M Buy
+11,600
New +$2.06M 1.78% 18

Other funds holding ORCL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Dilation Capital Management's ORCL Position: Q4 2025 in Review

Dilation Capital Management sold out of Oracle (ORCL) in Q4 2025, closing a stake of 16,080 shares — an estimated $4.52M sold.

Dilation Capital Management first reported a position in ORCL in Q4 2024 and held it in 2 quarters. The position peaked at $4.52M in Q3 2025. 3,772 funds tracked by Wall St. Rank hold ORCL as of Q4 2025.

  • Dilation Capital Management reported no remaining Oracle position as of Q4 2025 after selling out during the quarter.
  • Dilation Capital Management sold 16,080 Oracle shares in Q4 2025, an estimated $4.52M.
  • Dilation Capital Management first reported a position in Oracle in Q4 2024 and held it in 2 quarters.
  • Dilation Capital Management's Oracle position peaked at $4.52M in Q3 2025.
  • 3,772 funds tracked by Wall St. Rank held Oracle as of Q4 2025.

Based on Dilation Capital Management's 13F filing for Q4 2025, filed 9 Feb 2026.